梅特瘤基因:对驱动恶性病变的分子机制的30年的洞察力
Tiziana Crepaldi1,2, Simona Gallo1,2, Paolo Maria Comoglio3
1Department of Oncology, University of Turin, Regione Gonzole 10, 10143 Orbassano, Italy.
Pharmaceuticals (Basel, Switzerland)
|April 27, 2024
概括
通过激活信号通路,MET瘤基因驱动癌症. 针对MET提供了有前途的治疗策略,但了解像"爆发效应"这样的抵抗机制对于有效治疗至关重要.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症遗传学 癌症遗传学
背景情况:
- 编码肝细胞生长因子 (HGF) 受体的MET瘤基因在癌症的发展和进展中发挥着关键作用.
- HGF/MET信号传递对正常细胞功能至关重要,包括迁移,增殖和生存.
- 由于遗传变化的MET的构成激活驱动各种癌症的瘤发生.
研究的目的:
- 审查癌症中MET的分子机制.
- 突出MET作为治疗目标,并讨论抵抗机制.
- 探索选择性MET药理失活的策略.
主要方法:
- 关于MET瘤基因研究的科学文献的审查.
- 对与MET相关的遗传变异和信号通路的分析.
- 讨论治疗影响和耐药现象.
主要成果:
- 在MET中,遗传病变 (例如,放大,重新排列) 是瘤驱动因素和治疗点.
- MET过度表达,不总是由于基因放大,可以由各种因素诱导.
- 抑制MET可以导致一种
- 闪光灯效应的火焰效应
- 影响癌细胞增殖.
结论:
- 在过去的30年里,了解MET的作用使得癌症知识和治疗策略进步.
- 对MET的选择性药理失活是癌症缓解的一个有希望的方法.
- 需要包括MET抑制剂在内的组合疗法来克服耐药性.
相关概念视频
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Cancer-Critical Genes I: Proto-oncogenes
8.8K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.8K
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Induced Pluripotent Stem Cells
4.0K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
4.0K


